This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.
This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.
This document aims to inform and guide healthcare staff in NHS Wales about how to start nicotine replacement therapy (NRT) to manage nicotine withdrawal in adults who smoke and are admitted to hospital (secondary care).
The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.
The aim of these documents is to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.
This document updates the principles of best practice for shared care prescribing agreements.
This short ‘Best Practice Reminder’ document has been developed to inform primary care prescribers about avoiding the prescribing of nitrofurantoin in patients with suspected pyelonephritis, the rationale behind this and what can be prescribed in its place.
This resource pack provides healthcare professionals with signposting and access to appropriate, relevant and up-to-date information on the non-pharmacological and pharmacological management of persistent (chronic) non-malignant pain in non-specialist settings.
The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care and secondary care, in the essential counselling of patients on the safe and effective use of opioid patches.
This guideline aims to reduce variation in inhaler prescribing. Several audits in different health boards have demonstrated large variations in inhaler prescribing between different practices despite similar prevalence of asthma. Many health boards have produced local guidelines for asthma management, and it was discussed and agreed at Respiratory Health Implementation Group (RHIG) meetings that an All Wales guideline would be more effective than local plans.
This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.
This guideline focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and includes a Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment and recommendations from ‘Warfarin Monitoring’ (published in June 2012) relevant to the treatment of NVAF.
This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.
This project aims to reduce variation in inhaler prescribing.
The All Wales Guide to Prescribing Gluten-free Products aims to support general practitioners and other healthcare professionals in the management of patients with coeliac disease, and aid the decision-making process in relation to prescribing Advisory Committee on Borderline Substances (ACBS)-approved gluten-free foods.
These guidelines aim to provide comprehensive standardised guidance for the use of antimicrobials/treatment of infections in primary care across Wales.
This document aims to highlight and help address the patient safety issues associated with the long-term use of proton pump inhibitors (PPIs) in adults.
This guide supports the appropriate prescribing and supply of smoking cessation pharmacotherapy in NHS Wales for smokers who are motivated to quit.
The Common Ailments service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. The formulary was developed using recognised resources and involved multi-professional consultation to ensure the provision of consistent advice by pharmacists and GPs.
This policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process.